Author Guidelines

Human Subjects Research

Studies involving human participants must have approval from an appropriate institutional review board (IRB) or ethics committee. Authors must confirm that informed consent was obtained from all participants and that patient confidentiality has been protected. For case reports, written informed consent for publication must be obtained from patients or their legal guardians.

Animal Studies

Research involving animals must comply with institutional and national guidelines for the care and use of laboratory animals. Authors should provide details of the ethical approval and describe measures taken to minimize animal suffering.

Clinical Trials

Clinical trials must be registered in a publicly accessible database (e.g., ClinicalTrials.gov) before patient enrollment begins. The trial registration number should be included at the end of the abstract.

File Format and Language

Manuscripts should be submitted in Microsoft Word format (.doc or .docx). All submissions must be written in clear, grammatically correct English. Authors for whom English is not their first language may wish to have their manuscript professionally edited before submission.

Formatting

Use the following formatting throughout your manuscript:

• Font: Times New Roman, 12 pt
• Line spacing: Double-spaced throughout
• Margins: 2.5 cm (1 inch) on all sides
• Page numbering: Number all pages consecutively
• Line numbering: Enable continuous line numbering (aids peer review)

Title Page

The title page should include:

• Article title (concise and informative, avoid abbreviations)
• Full names and affiliations of all authors
• Corresponding author's contact information (email, phone, postal address)
• Word count (excluding abstract, references, and figure legends)
• Number of figures and tables

Abstract

Original Research Articles: Use a structured abstract (250-300 words) with the following headings: Background, Methods, Results, and Conclusions.

Review Articles: Provide an unstructured abstract (200-250 words) summarizing the main themes and conclusions.

Case Reports: Use a structured abstract with headings: Introduction, Case Presentation, and Conclusion (150-200 words).

Keywords

Provide 4-6 keywords below the abstract. Use terms from the Medical Subject Headings (MeSH) database where possible to improve discoverability.

Main Body Structure

Original Research Articles should follow the IMRaD format:

• Introduction: State the research question and objectives clearly
• Methods: Describe the study design, participants, procedures, and statistical analyses in sufficient detail to allow replication
• Results: Present findings logically, using tables and figures to support the text
• Discussion: Interpret the results, acknowledge limitations, and suggest future directions

Review Articles should include an Introduction, thematic sections organized by subtopic, and a Conclusion.

Case Reports should include: Introduction, Case Presentation (including patient history, examination, diagnosis, treatment, and outcome), Discussion, and Conclusion.

For additional content types, please refer to our Content Types page.

Figures and Tables

Figures and tables should be cited in the text in numerical order and should be self-explanatory:

• Figures: Submit as separate high-resolution files (minimum 300 dpi, TIFF, JPEG, or PNG format). Include concise captions below each figure.
• Tables: Create using Word's table function (not as images). Number consecutively and provide a descriptive title above each table.
• Ensure all abbreviations used in figures and tables are defined in the caption or footnote.

Supplementary Materials

Authors may submit supplementary materials (e.g., datasets, extended methods, additional figures) that will be published online alongside the article. Ensure supplementary files are clearly labeled and cited in the main manuscript.

Common Reference Examples

Journal Article:

Smith, J. A., & Johnson, B. C. (2023). Advances in gene therapy for rare diseases. Journal of Medical Research, 45(3), 123-145. https://doi.org/10.1234/jmr.2023.45.3.123

Book:

Brown, L. M. (2022). Principles of immunology (3rd ed.). Academic Press.

Website:

World Health Organization. (2023, January 15). Global health statistics. https://www.who.int/data/global-health-statistics

For comprehensive APA formatting guidance, consult the official APA Style Guide.

Review Stages

1. Editorial screening (3-5 days): The Editor-in-Chief or a Senior Editor assesses whether the manuscript fits the journal's scope and meets basic quality standards.
2. Peer review (4-6 weeks): If the manuscript passes initial screening, it is sent to at least two independent reviewers with expertise in the relevant field.
3. Editorial decision (1-2 weeks after reviews received): The editor evaluates reviewer comments and makes a decision.

Possible Outcomes

• Accept: The manuscript is accepted without further changes.
• Minor revision: Small changes are required; typically reviewed by the editor only.
• Major revision: Substantial revisions needed; manuscript returns to reviewers after revision.
• Reject: The manuscript is not suitable for publication in RevisX.

Fee Structure

• Standard APC: $65 USD
• Fees are charged only after manuscript acceptance, not at submission.

Waivers and Discounts

RevisX offers APC waivers or discounts on a case-by-case basis for authors from low-income countries or those facing genuine financial hardship. To request a waiver, please submit a brief statement explaining your circumstances in your cover letter at the time of submission. All waiver requests are reviewed confidentially by the editorial board.

Proof Review

Authors will receive a typeset proof of the article for review. At this stage, only minor corrections (e.g., typos, formatting errors) are permitted. Substantial changes to content cannot be accommodated during proofing. Authors typically have 72-96 hours to return corrected proofs.

Publication Timeline

After proof approval and APC payment, articles are published online within 2-3 weeks.

Open Access License

All articles published in RevisX are licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing unrestricted use, distribution, and reproduction in any medium, provided proper attribution is given.

Plagiarism and Originality

All submissions are screened for plagiarism using detection software. Manuscripts with substantial overlap with published work (including author's own previous publications) will be rejected. Proper citation of all sources is mandatory.

Conflicts of Interest

All authors must disclose any financial, professional, or personal relationships that could be perceived as influencing their research. If no conflicts exist, this should be explicitly stated in the manuscript.

Data Availability

Authors are encouraged to make the data underlying their research publicly available in an appropriate repository. Data availability statements should be included in the manuscript, specifying where and how data can be accessed.

Corrections and Retractions

If significant errors are identified post-publication, the journal will issue corrections, errata, or, in cases of serious misconduct or fundamental flaws, retractions in accordance with COPE guidelines.

Use of AI in Manuscript Preparation

Authors may use AI tools for language editing, grammar checking, or literature searching. However, AI cannot be listed as an author, and any use of AI in manuscript preparation must be disclosed in the methods or acknowledgments section. Authors remain fully responsible for the content and accuracy of their work.

Helpful Resources

• Download RevisX's Author Guideline Document
• Submission Portal
• Content Types
• Editorial Policies
• APA Style Guide